Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
about
Oligodendrogenesis in the normal and pathological central nervous systemMimicking Neural Stem Cell Niche by Biocompatible SubstratesInfection as an Environmental Trigger of Multiple Sclerosis Disease ExacerbationLeukemia inhibitory factor (LIF)Stem cell therapy for central nerve system injuries: glial cells hold the keyA staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsThe stem cell secretome and its role in brain repair.Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitroDonor mesenchymal stem cell-derived neural-like cells transdifferentiate into myelin-forming cells and promote axon regeneration in rat spinal cord transection.Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelinationMicroglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.Engineering an in situ crosslinkable hydrogel for enhanced remyelination.Effects of Controlled Cortical Impact on the Mouse Brain Vasculome.Activation of oligodendroglial Stat3 is required for efficient remyelination.Oligodendroglia and neurotrophic factors in neurodegeneration.Role of leukemia inhibitory factor in the nervous system and its pathology.Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.A shRNA functional screen reveals Nme6 and Nme7 are crucial for embryonic stem cell renewal.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)A new model of cuprizone-mediated demyelination/remyelination.Peripherally derived FGF21 promotes remyelination in the central nervous system.HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.Stem cell therapy versus T lymphocytes: friend or foe?Protective effect of miconazole on rat myelin sheaths following premature infant cerebral white matter injury.Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF.
P2860
Q21129352-9BD69D7F-85F5-4DC5-9BBA-33F9D976C5F3Q26765921-6EE2AD43-95B3-4A08-A341-B54B6C266193Q26779416-DD0936E4-38C4-470E-BF1B-F73781B2B020Q28082576-EF044ACE-27F0-4703-B680-875E091DF22BQ28394140-9EE4B414-846A-4331-B3AF-39F8657D7BEEQ30844551-246D10E0-8FF8-4DEC-A8C1-16EAA1A7112CQ33771698-661D4C30-2B55-41B8-B456-571EB0C018C2Q34241152-DB15D0BC-8105-41AE-A4C3-E9A0482DF8F4Q35067385-65F1A77D-7274-40ED-8DF1-35FBC2B72A08Q35642341-8F58113E-0679-4A5D-920A-70082392DA77Q36355088-5DDABB5F-D6BC-42FF-848A-194849ED345EQ36486079-FDCB28BE-396F-4C71-9CB9-B1EE6BD8EF96Q36615147-7223683E-D4C5-4E55-BA7B-03E29FBD4DF5Q37062141-F429A670-F6F2-453A-A5DB-BD8B1E9DD8F2Q37129632-B29B1DB8-7362-470B-B531-7849621BB6B1Q38096248-E4A78DDC-5D6D-4B86-B71C-97C1D5497F7BQ38423423-742B8BAD-2689-4D90-8ECA-FD984173CE35Q38534740-709A22B7-FA08-45CB-B5C7-80C0584947B4Q38865496-662508AC-6C71-4546-8FC8-5BFCC7235CF3Q39047793-EE80BECB-58E2-4B2C-A58A-D5188B1C34E8Q39296177-C5BD99CF-FE6A-43BB-9F66-E48ED28B9679Q40617937-96772F20-8B81-4836-B1F7-1F33540B0918Q41761293-9151307B-0A10-4C05-BEFF-309B1B1BA7E3Q47927815-3AF2ED06-0A2A-4855-BBEB-A76B11D23772Q48455443-E3520667-B1A0-4E50-8181-F551F629A277Q48490621-705D911B-B088-43FE-858D-05F8B8A26B02Q49884433-5895AF54-C763-45E8-A7EC-DFDA474D26B4Q49961729-E80E4190-B4C2-4750-B9BF-FCF3B7ECFC12Q55248103-F11C806F-3E21-4A01-B0D0-E68FE5408A4A
P2860
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@ast
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@en
type
label
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@ast
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@en
prefLabel
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@ast
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@en
P2860
P1476
Exogenous leukemia inhibitory ...... ces hippocampal remyelination.
@en
P2093
Paul H Patterson
P2860
P304
P356
10.1523/JNEUROSCI.3803-11.2012
P407
P577
2012-02-01T00:00:00Z